According to the recent Healthkoreanews' reserch on 15 Korean small and medium Pharmaceutical companies(which had under 100 billion sales a year), 14 companies have increased their sales, 11 companies their operating profits, and 12 companies their net profits in 2008.
Korea United Pharm has increased its sales, operating profit and net profit, thanks to the skyrocketing exchange rate. Especially its sales have recorded 94.7 billion won, up 58.6 percent from 56.7 billion won of last year and operating profit has recorded 12.2 billion won, up 74.2 percent from 7 billion won of last year.
The sales of Huons also have recorded 74.4 billion won, up 18.9. percent from 63.0 billion won of last year.
The sales of Whan In Pharm have recorded 92.9 billion won, compared with 80.0 billion won of last year, and those of Han All Pharmaceutical 91.9 billion won compared with 82.4 billion won of last year. Daihan, Jin Yang and Seoul have respectively recorded 20.15 percent, 27.8 percent, 48 percent increasing compared with last year.
But the sales of Wooridul Life Sciences have recorded 76.6 billion won down 1.1 percent from 78.5billion won of last year. <헬스코리아뉴스>
저작권자 © 헬스코리아뉴스 무단전재 및 재배포 금지